511 related articles for article (PubMed ID: 8185423)
1. Usefulness of soluble interleukin 2 receptor in differentiating tuberculous and carcinomatous pleural effusions.
Chang SC; Hsu YT; Chen YC; Lin CY
Arch Intern Med; 1994 May; 154(10):1097-101. PubMed ID: 8185423
[TBL] [Abstract][Full Text] [Related]
2. Preliminary evaluation of soluble IL-2 receptor and type III procollagen N-terminal aminopeptide in pleural fluid for differentiating tuberculous, carcinomatous and parapneumonic pleural effusions.
Harita S; Nogami N; Kikuchi T; Kibata M
Respirology; 2002 Dec; 7(4):311-5. PubMed ID: 12421238
[TBL] [Abstract][Full Text] [Related]
3. Pleural fluid and serum soluble interleukin-2 receptors in pleural effusions.
Sarandakou A; Poulakis N; Rizos D; Phocas I
Anticancer Res; 1991; 11(3):1365-8. PubMed ID: 1888173
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of tuberculous pleuritis by the measurement of soluble interleukin 2 receptor in pleural fluid.
Porcel JM; Gázquez I; Vives M; Pérez B; Rubio M; Rivas MC
Int J Tuberc Lung Dis; 2000 Oct; 4(10):975-9. PubMed ID: 11055766
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of soluble interleukin 2 receptor alpha in the pleural fluid].
Ni SS; Gao ZL
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):81-2, 123. PubMed ID: 8221956
[TBL] [Abstract][Full Text] [Related]
6. [Elevated soluble interleukin-2 receptor and interleukin-2 receptor positive cells in carcinomatous pleural effusions].
Kojiro N; Moriwaki Y; Ito M; Nishiki M; Shirasaka T; Kokubu T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):100-4. PubMed ID: 2355670
[TBL] [Abstract][Full Text] [Related]
7. Gamma-interferon and soluble interleukin 2 receptor in tuberculous pleural effusion.
Kim YK; Lee SY; Kwon SS; Kim KH; Moon HS; Song JS; Park SH
Lung; 2001; 179(3):175-84. PubMed ID: 11891607
[TBL] [Abstract][Full Text] [Related]
8. Pleural fluid soluble interleukin 2 receptor in rheumatoid arthritis and systemic lupus erythematosus.
Pettersson T; Söderblom T; Nyberg P; Riska H; Linko L; Klockars M
J Rheumatol; 1994 Oct; 21(10):1820-4. PubMed ID: 7837144
[TBL] [Abstract][Full Text] [Related]
9. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
Zhou WB; Bai M; Jin Y
Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
[TBL] [Abstract][Full Text] [Related]
11. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.
Castaño Vidriales JL; Amores Antequera C
Eur J Med; 1992; 1(4):201-7. PubMed ID: 1341445
[TBL] [Abstract][Full Text] [Related]
12. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.
Liu CL; Hsieh WY; Wu CL; Kuo HT; Lu YT
Respir Med; 2007 May; 101(5):903-9. PubMed ID: 17097866
[TBL] [Abstract][Full Text] [Related]
13. Neopterin, soluble interleukin-2 receptor and adenosine deaminase levels in pleural effusions.
Chiang CS; Chiang CD; Lin JW; Huang PL; Chu JJ
Respiration; 1994; 61(3):150-4. PubMed ID: 8047718
[TBL] [Abstract][Full Text] [Related]
14. Differentiating tuberculous from malignant pleural effusions: a scoring model.
Porcel JM; Vives M
Med Sci Monit; 2003 May; 9(5):CR175-80. PubMed ID: 12761453
[TBL] [Abstract][Full Text] [Related]
15. Determination of adenosine deaminase activity and its isoenzymes for diagnosis of pleural effusions.
Gorguner M; Cerci M; Gorguner I
Respirology; 2000 Dec; 5(4):321-4. PubMed ID: 11192541
[TBL] [Abstract][Full Text] [Related]
16. Elevated soluble CD26 levels in patients with tuberculous pleurisy.
Oshikawa K; Sugiyama Y
Int J Tuberc Lung Dis; 2001 Sep; 5(9):868-72. PubMed ID: 11573900
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions.
Okamoto M; Kawabe T; Iwasaki Y; Hara T; Hashimoto N; Imaizumi K; Hasegawa Y; Shimokata K
J Lab Clin Med; 2005 Feb; 145(2):88-93. PubMed ID: 15746651
[TBL] [Abstract][Full Text] [Related]
18. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.
Chierakul N; Kanitsap A; Chaiprasert A; Viriyataveekul R
Respirology; 2004 Mar; 9(1):66-9. PubMed ID: 14982604
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin is upregulated in malignant and inflammatory pleural effusions.
Moschos C; Porfiridis I; Psallidas I; Kollintza A; Stathopoulos GT; Papiris SA; Roussos C; Kalomenidis I
Respirology; 2009 Jul; 14(5):716-22. PubMed ID: 19476604
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion.
Chan MC; Chang KM; Chao WC; Lin LY; Kuo BI; Hsu JY; Wu CL
Respirology; 2007 May; 12(3):333-8. PubMed ID: 17539835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]